亿胜生物科技(01061.HK):未来数月业务可能受疫情影响
亿胜生物科技(01061.HK)表示,由於内地多个省市已启动不同级别的重大突发公共卫生事件应对措施,影响医院非紧急门诊日常运作,对集团制造及销售治疗体表创伤及眼部损伤修复的生物药品业务也造成影响,倘有关措施并未於短期内撤销,随後数月之营业额及业绩将会造成负面影响。
公司指,目前基础研发项目及正在海外进行之临床试验计划及营运会如常进行,所受影响轻微。
亿胜生物科技并向一个主要人道主义组织捐款500万元人民币现金,用作於武汉兴建医院及於珠海实施防控工作,同时捐赠价值250万元人民币的皮肤科产品予缓前线医护人员。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.